Fig. 5
From: G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
GPCRs-targeting drugs for neurodegenerative diseases and psychiatric disorders. a Numbers of compounds approved for clinical use or under clinical trials. b Summary of the action modes of GPCR-targeted agents for treatment of neuropsychiatric diseases
